Observational Descriptive and Comparative Study of Patients Over 70 Years Old with Lung Cancer Oligometastasis Treated with a Radiotherapy Technique called SABR

Identifier:  TFM:1897

Handle: https://hdl.handle.net/20.500.11797/TFM1897

Authors:  Yuan, Mengfei

Abstract:
Lung cancer has become the leading cancer worldwide. SABR has emerged as a highly precise radiotherapy treatment, a promising treatment option for oligometastatic lung cancer patients. The objective is to investigate the clinical radiation response and toxicity in oligometastatic lung cancer of elderly patients. By analyzing the factors that might influence the outcomes and acute or chronic toxic reactions, any significant differences were founded. SABR is a good treatment option for older patients, demonstrating neither increased toxicity nor worse clinical responses. The treatment tolerance, response, and toxicity results are similar to those in the population under 70 years old